FDA Investigator Richard Heath Coats
Richard Heath Coats has conducted inspections on 17 sites in 7 countries as of 03 May 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
17
Last Inspection Date:
03 May 2024
Investigator Role:
FDA Investigation Participant
Redica ID:
Countries of Inspections:
Netherlands,
United States of America,
France,
Switzerland,
United Kingdom of Great Britain and Northern Ireland,
Australia,
Korea (Republic of)
FDA Investigators that have inspected at least one site in common with Richard Heath Coats:
Alexander M Kay,
Alexey Khrenov, PhD,
Andrew F Shrake,
Anthony A Charity,
Ashley L Reiber,
Barbara J Holladay,
Barbara Janine Breithaupt,
Barbara M Frazier,
Binh T Nguyen,
Bonita S Chester,
Bradley Dworak, PhD,
Brenda L Reihing,
Brentley S Collins,
Brian D Nicholson,
Bryan Baker,
Burnell M Henry,
Byungja E Marciante,
Carrie Ann Plucinski,
CDR Donald Ertel,
Chaltu Nwakijra,
Charles R Bonapace, PhD,
Christian D Lynch (CDL),
Christine A Harman, PhD,
Christine M Whitby, CSO,
Christopher R Czajka,
Claire M Minden,
Cynthia A Harris, MD, RN,
Cynthia Jim, CSO,
Daniel C Kearns,
Daniel R Azar,
David Perkins,
Deborah M Trout,
Debra Bower,
Debra I Love,
Decarlos A Gomez,
Dennis Cantellops Paite,
Devaughn Edwards,
Deyaa Shaheen,
Dianna D Wardlow Dotter,
Dolores E Price,
Douglas A Campbell,
Dr. Mark J Seaton, PhD,
Dr. Zhou Chen (nmi), MD PhD,
Edward D Harris,
Eileen A Liu,
Elena Karnaukhova, PhD,
Eliezar Ramos,
Emest F Bizjak,
Erin L Mcfiren,
Ewa Marszal, PhD,
Francis A Guidry,
Frank W Perrella,
Gabriel M Guevarra,
Gene D Arcy,
Gregory Price,
Helen B Ricalde,
Humera T Khan,
Jacqueline Mdiaz Albertini,
James A Jagon,
James D Planchon,
James P Stumpff,
James R Evans,
Jason F Chancey,
Jeanne M Morris,
Jennifer L Schmidt,
Jessica L Walters Moell,
Joan Johnson,
John Godshalk,
John M Seale,
Jorge L Guadalupe,
Jose Acruz Gonzalez,
Joseph George,
Julie D Bringger,
Jyoti B Patel, PhD,
Kaarin M Slotte,
Katherine E Jacobitz,
Kathryn A Krentz,
Kenneth Nieves,
Kham Phommachanh,
Kimberley A Hoefen,
Kula N Jha,
Kurt A Brorson, PhD,
Lakisha M Williams,
Laura Fontan, MS,
Laurel A Beer,
LCDR Debra Emerson,
LCDR Randall L Morris,
Lynette P Salisbury,
Madushini Dharmasena, PhD,
Malgorzata G Norton, PhD,
Marisol Faberlle,
Marissa S Steinhagen,
Mariza M Jafary,
Marvin D Jones,
Michael C Kennedy, PhD,
Michael F Skelly, PhD,
Michael R Goga,
Mihaly S Ligmond,
Mra Mcculloughj,
Nancy T Waites,
Nebil A Oumer,
Nicole K Trudel,
Nobuko H Katagiri,
Norman K Starks,
Olga Simakova, PhD,
Omotunde O Osunsanmi,
Patrick L Wisor,
Paula A Trost,
Peng Zhou,
Pete Amin (Pankaj),
Peter Kessler, PhD,
Philip J Snoy,
Prabhu P Raju,
Rachel C Harrington,
Ralph A Erickson,
Raymond W Brullo,
Rebecca K Olin,
Rebecca T Davis,
Reyes Candau Chacon, PhD,
Richard T Riggie,
Robert C Coleman,
Robert D Tollefsen,
Robert Jennings,
Robert L Hummel,
Rocco C Black,
Roger F Zabinski,
Rose Ashley,
Russell K Riley,
Samuel W Labinjo,
Sangeeta M Khurana, PhD,
Scott E Norris,
Scott T Ballard,
Shafiq S Ahadi,
Shirley J Berryman,
Sidney B Priesmeyer,
Simone E Pitts,
Sonya L Karsik, RAC,
Stephanie L Shapley,
Stephen D Brown,
Stephen R Souza,
Steven C Madzo,
Steven M Weinman,
Steven P Donald,
Sunitha K Rajaram, PhD,
Susan M Jackson,
Susan P Bruederle,
Susan Yu,
Tamala P Bogan,
Tamala P Magee,
Tania Y Hall,
Tara G Bizjak,
Tara R Gooen,
Terri L Dodds,
Toyin B Oladimeji,
Travis S Bradley,
Unnee Ranjan,
Vanessa Y Gelsey, PhD,
Vanessa Y Jacobs,
Vijaya L Simhadri,
Wayne T Smith,
Wei Wang, PhD,
Xiuju Lu,
Yonggang Wang, PhD,
Zhongren Wu
Richard Heath Coats's Documents
| Publish Date | Document Type | Title |
|---|---|---|
| June, 2016 | FDA 483 | GC Biopharma Corp_Ochang Plant - Form 483, 2016-06-21 |
| August, 2013 | FDA 483 | BioReliance Corporation - Form 483, 2013-08-29 |
| April, 2014 | EIR | N.V. Organon - EIR, 2014-04-08 |
| October, 2015 | FDA 483 | CSL Behring (Australia) Pty Ltd - Form 483, 2015-10-09 |
| March, 2019 | FDA 483 | Bavarian Nordic Berna GmbH - Form 483, 2019-03-15 |
| July, 2013 | EIR | Stallergenes - EIR, 2013-07-02 |
| April, 2016 | FDA 483 | SynCo Bio Partners Bv - Form 483, 2016-04-06 |
| July, 2013 | FDA 483 | CENEXI - Form 483, 2013-07-05 |
| July, 2013 | FDA 483 | Stallergenes - Form 483, 2013-07-02 |
| August, 2013 | EIR | BioReliance Corporation - EIR, 2013-08-29 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more